A novel oncogene, rsc (rabbit squamous cell carcinoma), has been identi®ed from a DMBA-induced rabbit squamous cell carcinoma using gene transfer and the nude mouse tumorigenesis assay. A full-length cDNA has been isolated and sequenced. rsc has potent tumorigenic activity in nude mice (latency 54 weeks), but does not induce focus formation or anchorage independent growth. The oncogene resulted from the fusion of rHR 23A (a rabbit homologue of yeast Rad 23) with a member of the ral-GDS family which we named rgr (ral-GDS related). Deletion analysis demonstrated that the oncogenic potential resides in the Rgr portion of the gene. Rgr is 40% identical overall to Ral-GDS, with identity increasing to 72% over a 100 amino acid region of the catalytic domain. Biochemical experiments indicate that Rgr has GTP/GDP exchange activity for Ral, providing evidence that this pathway is associated with tumorigenesis. The linkage between the Ral pathway and tumorigenesis by a molecule in the Ral-GDS gene family (Ral-GDS being a known eector for Ras) will open the way for the characterization of this pathway and provide an important tool to understand its biological function.
Introduction
The identi®cation and characterization of the dierent genes that contribute to the tumorigenic process (oncogenes and tumor suppresser genes) has been one of the principal objectives of molecular oncology in recent years. The discovery that endogenous genes were activated in many malignancies was the breakthrough that gave impetus for the development of the ®eld (Bishop, 1991) .
Our laboratory has utilized animal model systems of tumorigenesis in which ras mutations frequently occur (Guerrero and Pellicer, 1987; Mangues and Pellicer, 1992; Leon and Pellicer, 1993) . One such system is the induction of skin tumors in rabbits by topical treatment with dimethylbenzanthracene (DMBA). The animals develop benign papillomas and keratoacanthomas (KAs), and malignant squamous cell carcinomas (SSCs) (Ghadially, 1988) . In KAs the frequency of H-ras activation was over 80%, but in SSCs it is approximately 40% (Leon et al., 1988; Corominas et al., 1991) . We decided to use the nude mouse tumorigenesis assay (Fogh and Giovanella, 1978) to identify genes other than ras involved in our model system. Gene transfer has been an important method for isolation of oncogenes, because even if some of the genes detected did not play a role in the original tumor (Nakamura et al., 1988) , genes with oncogenic potential are often key regulatory molecules in the process of cellular proliferation (Taira et al., 1987; Santoro et al., 1993; Watkins et al., 1994) . Oncogenes detected by gene transfer were often previously unknown, or their signi®cance had not been appreciated (Cantley et al., 1991) . Because the focus forming assay frequently detects ras oncogenes we decided to use the nude mouse assay, which has identi®ed other previously unknown oncogenes (Fasano et al., 1984) .
One of the ®elds where oncogenes have made a notable contribution is in signal transduction. Many of the gene products that convey a signal from growth factors to the nucleus (where they induce activation of transcription factors) are oncogenes when they are activated by improper expression or genetic alterations. These include the EGF receptor, shc, ras, raf, fos and jun, which score positive in gene transfer assays (Cantley et al., 1991) . Among the best studied signal transduction pathways are those mediated by small GTPases that belong to the Ras supergene family (Schlessinger and Ullrich, 1992) . The Ras pathway is involved in directing cell proliferation, and the Rho family pathways have been shown to be responsible for regulating the actin stress ®bers in the cytoskeleton and therefore play an important role in cell morphology (Nobes and Hall, 1995) . On the other hand the pathway mediated by Ral seems to activate phospholipase D (PLD) (Jiang et al., 1995) and a Ral eector, named Ral BP1 (Cantor et al., 1995) or RIP 1 (Park and Weinberg, 1995) , has rho-GAP activity, but its members had not been reported to be oncogenic. In the present study, we have isolated a novel oncogene that has signi®cant homology with Ral-GDS (Ral guanine dissociation stimulator) (Albright et al., 1993) , a molecule that has been shown to be also a Ras eector (Hofer et al., 1994; Spaargaren and Bischo, 1994) . We named this oncogene rgr for Ral-GDS related. Therefore, the results presented in this report potentially link the Ral pathway to tumorigenesis and provide new evidence to assign this pathway a role in the proliferation and morphological changes observed in cell transformation.
Results

Isolation of oncogene sequences
DNA was extracted from eight rabbit ear skin SSCs induced by treatment with DMBA (Corominas et al., 1991) . The nude mouse tumorigenesis assay was utilized to determine if the DNAs contained any dominant oncogenes. Those tumors that showed transfer of a ras gene were eliminated. Three others were positive in the primary round of tumorigenesis, but only one, O1, was positive during a secondary round of transfection and tumorigenesis. This tumor was chosen for further characterization. Southern analysis did not show activation of other genes previously detected by gene transfer (raf, erbB, mas, etc.) . It was concluded that the nude mouse tumors did not result from the transfer of any of the oncogenes tested (data not shown). We considered it likely that the transforming activity was derived from a novel oncogene.
To follow the rabbit sequences on a mouse background, a rabbit repetitive sequence (RRP) (Cheng et al., 1984) was utilized to probe Southern blots with DNAs from subsequent transfers from the tumor O1 (Figure 1) Figure 1 Maintenance of a rabbit repetitive element and a single copy rabbit sequence through successive nude mouse tumors. (a) 20 mg of genomic DNA from each tumor or cell line was digested with the various restriction enzymes listed and electrophoresed through a 0.8% agarose gel. The DNA was transferred to a nitrocellulose ®lter by Southern blotting (as described in Materials and methods). The ®lter was probed with the rabbit C29 repetitive element. The samples are as follows: O1 ± primary nude mouse tumor, derived from 3T3 cells transfected with DNA from rabbit O1 Squamous Cell Carcinoma; O12.1 ± secondary nude mouse tumor; O13.1 ± tertiary nude mouse tumor. (b) The ®lter in (a) was stripped and reprobed with the 1.2 kb single copy rabbit probe p8.12 (Novick, 1994) . This probe was derived from a phage clone that had been obtained by screening a nude mouse tumor genomic library with the repetitive element probe rsc oncogene homologous to Ral-GDS D D'Adamo et al were maintained through three rounds of transfer, making the isolation feasible. A cell line designated RSC 3.1 was established from a tertiary tumor to facilitate the isolation of DNA and RNA from oncogene-transformed cells. A DNA genomic library from the tertiary tumor O1.3 was constructed and screened with the RRP. Seven clones were isolated, but none of them contained transcribed sequences. A single copy rabbit probe isolated from one of the clones was used to rescreen the genomic library to obtain sequences further away which might contain exons. Twelve clones were isolated in this chromosome walking and one of them, O1.2-2, hybridized to a transcript of approximately 2.4 kb in the RSC 3.1 tumor cell line, which was not detected in 3T3 cells (Figure 2 ).
Oncogene cDNA isolation
To determine which part of the 12 kb genomic insert contained exonic sequences, the clone was digested with restriction enzymes. The fragments were separated by agarose gel electrophoresis and transferred to a nylon ®lter. This ®lter was probed with 32 P-labeled cDNA synthesized from poly (A) + RNA from the RSC 3.1 tumor cell line. These experiments identi®ed a 2.5 kb BamHI fragment and subsequently a 700 base Sau3a subfragment which contained transcribed sequences. These 700 bases were sequenced and revealed a region of homology to HHR 23A, a human gene homologue of yeast rad 23 (Masutani et al., 1994) . We named the gene rHR23A (rabbit homologue of rad 23). Primers for the RACE technique (see Materials and methods) were synthesized using this sequence data. In the RACE procedure, we used ds cDNA synthesized from poly (A) + RNA of RSC 3.1 cells which yielded two fragments: a 5' segment of 0.5 kb and a 3' segment of 2.2 kb. A rsc (rabbit squamous cell carcinoma) cDNA containing the entire coding region was generated by PCR from RSC 3.1 cDNA ( Figure  3) . The 3' primer was only several bases upstream of the poly A tail. The 5' primer contains only 11 out of 36 bases of 5' UTR, because the 5' UTR of rHR23A is extremely GC rich and dicult to amplify by PCR. This almost full-length cDNA containing the entire coding region of rsc was subcloned into pCR II (Invitrogen). The insert was excised by EcoRI digestion and ligated into the vector pBK-CMV (Stratagene), which had been modi®ed to a (lac 7 ) version. To increase eukaryotic expression, the bacterial lac promoter was removed by digesting with the restriction endonucleases Nhel and SpeI. The vector was gel puri®ed, and the compatible ends were religated. The presence and orientation of rsc in pBK-CMV (lac 7 ) were determined by digestion with the restriction endonucleases BamHI and BstEII. The nude mouse tumor assay demonstrated that the cloned rsc cDNA possessed transforming activity (Table 1) .
rsc oncogene cDNA sequence
Comparison of the rsc cDNA sequence with the EMBL database revealed two seemingly unrelated parts. The ®rst 785 bases coded for a protein that had more than 95% amino acid identity with HHR23A, the human homologue of the yeast gene rad 23. The homology was abruptly lost after the ®rst 785 bases, and the following 1.4 kb showed 60% identity to the mouse cDNA sequence for ral-GDS (Albright et al., 1993) . This result indicates that a fusion between two genes most likely occurred in the activation process. Rsc contains only the ®rst 258 amino acids out of the 363 present in the human HHR23A protein (Masutani et al., 1994) . This includes a ubiquitin-like domain that is present in both genes. The high degree of identity of the 5' region of rsc with HHR23A indicates that they are most likely the same gene; the dierences are probably due to species variation. In contrast, the identity with Ral-GDS is 60% on the nucleotide level, yet at the protein level it is only 40% over 490 amino acids, indicating that the sequences present in rsc code for a novel gene in the ral-GDS family. This gene was named rgr (ral-GDS related). The identity in the catalytic or CDC25 domain rises to 72% (Figure 4) , reinforcing the functional relationship with Ral-GDS. The rsc cDNA has an open reading frame of 748 amino acids, which starts at the ®rst codon of rHR23A and ®nishes with a termination codon and a 3' untranslated sequence of 246 bases that contains a Figure 2 The insert of phage clone 2.2 contains exons of a gene expressed in the RSC 3.1 cell line but not in the parental 3T3 cells. Fifteen mg of total RNA from 3T3 and 3.1 cell lines were analysed by Northern blotting (1% gel). The ®lter was hybridized to a 2.5 kb BamHI fragment of clone 2.2 (Figure 3) polyadenylation signal. The 3'-UTR shows no detectable homology to the 3'-untranslated region of ral-GDS.
The ral-GDS (Guanine nucleotide Dissociation Stimulator) gene codes for a protein which acts as a GTP/GDP exchange factor for Ral. Ral is a small GTP binding protein in the Ras family. Three independent laboratories have identi®ed Ral/GDS in the yeast two hybrid system as interacting with the GTP bound (active) form of Ras (Hofer et al., 1994; Kikuchi et al., 1994; Spaargaren and Bischo, 1994) . Interestingly, it is the C terminal domain of Ral/GDS that interacts with Ras. This domain is not present in Rsc.
Rgr is a member of the CDC25 family
The deduced amino acid sequence of the Ral/GDS related domain was compared with the EMBL database using the computer program TFASTA (Genetics Computer Group, 1987) . Over 20 genes were scored as having regions of signi®cant homology (data not shown). Most of these genes belong to the CDC25 family of guanine nucleotide exchange factors. A representative sample of these genes was analysed for domains of homology using the computer program MACAW (Schuler et al., 1991) . Three domains scored as signi®cantly homologous in six or more of the nine genes. They are shown in schematic form ( Figure 5 ).
Mechanism of rsc activation
In order to determine the mechanism of activation of the oncogene it was necessary to isolate the counterparts of rHR 23A and rgr from a normal rabbit tissue. To ®nd tissues expressing those normal counterparts probes generated during the rsc cDNA characterization, speci®c for each gene, were used to probe Northern blots containing RNAs from various rabbit tissues and the rabbit cell line RK13. The result indicates that rHR23A is expressed at low levels in several of the tissues analysed (data not shown). We chose to isolate the wild type cDNA for rHR23A from rabbit brain. The rgr probe did not produce signal in any of the tissues analysed. Speci®c amplimers were designed to perform RT ± PCR analysis of rgr expression. Although ethidium bromide staining of the RT ± PCR ampli®cation failed to reveal any bands, subsequent hybridization of the blotted gel with an rgr speci®c probe showed that some expression could be detected in lung, skin and the RK13 cell line derived from rabbit kidney (data not shown).
The RACE technique previously used to isolate the rsc cDNA was utilized here as well, to obtain a near full-length normal rabbit cDNA for rHR23A. The rHR23A normal cDNA initiates at the same point as rsc and the deduced amino acid sequence was identical until the fusion point, showing that no additional alterations had occurred besides the truncation at Figure 3 The nucleotide and deduced amino acid sequence of the rabbit rsc cDNA. The sequence was obtained from two overlapping RACE products. The initiating ATG, depicted with a box around it, begins at base 12. The ®rst in frame stop codon at base 2256 has an asterisk underneath. A poly-adenylation signal (ATTAAA) is underlined at base 2460. The junction between the rHR23A and the ral/GDS-related portions of the gene lies at codon 258 and is highlighted by a vertical arrow rsc oncogene homologous to Ral-GDS D D'Adamo et al position 785 and fusion to rgr. A partial cDNA of rgr, containing the region that is present in rsc, was obtained by RT ± PCR from poly (A) + RNA. Likewise, the rgr region of the rsc cDNA did not contain point mutations compared with its normal counterpart. The RK13 rgr partial cDNA that we isolated contained a stop codon and a 3' UTR identical to rsc, including a functional polyadenylation signal. This cDNA did not contain the 5' end of rgr. Strictly, we do not know how large this region is, but by analogy with Ral/GDS we expect it to be around 130 amino acids ( Figure 4 ). These results indicate that the activation most likely occurred by DNA rearrangement, although we cannot completely rule out overexpression, and the oncogenic properties could be due to the speci®c fusion of these two genes or to accidental truncation of either one of them during the fusion. To dierentiate between these two possibilities, the portion of the cDNAs for rHR23A and rgr present in rsc were independently subcloned into the expression vector pCR III (Mead et al., 1991) , including the provision of a translation initiation codon for the truncated rgr. These constructs were tested in the nude mouse tumorigenesis assay. The results indicated that only rgr retained tumorigenic properties (Table 2) . To ascertain if overexpression of the normal rHR23A could be responsible for the tumorigenic phenotype, a construct with the normal full length cDNA was also subcloned into the same vector and tested for its tumorigenic potential. rHR23A (both the segment present in rsc, and the full-length cDNA) scored negative in the assay, while the Figure 4 The CDC25/catalytic domain of RSC is 72% identical to the corresponding domain of Ral/GDS (Albright et al., 1993) . The amino acid sequences of the catalytic domains of RSC and Ral/GDS were compared using the computer program TFASTA (Genetics Computer Group, 1987). The italicized region represents the catalytic domain. Figure 5 The RSC ral/GDS related domain belongs to the CDC25 family of GDP/GTP exchange factors. Sequence comparison of RSC with the CDC25 family. The computer program MACAW (Schuler et al., 1991) was used to identify blocks of conserved sequence among CDC25 family members. Each protein is illustrated as a horizontal box with the gene name to the left of the box. The ruler at the bottom of the ®gure represents the number of amino acids. Hatched regions indicate blocks which represent statistically signi®cant similar regions found in six or more of the proteins. The hollow boxes represent the protein sequence of unrelated or less closely conserved regions of these proteins. The genes are as follows: ral/GDS ± mouse ral Guanine nucleotide Dissociation Stimulator (Albright et al., 1993) ; RGL ± mouse ral/GDS Like protein (Kikuchi et al., 1994) ; mCDC25h ± mouse CDC25 homologue (Cen and Lowy, 1992) ; Ras-GRF ± human ras Guanine nucleotide Releasing Factor (Shou et al., 1992) ; hCDC25h ± human CDC25 homologue (Wei and Broek, 1993) ; mSOS-1 ± mouse Son of Sevenless (Bowtell et al., 1992) ; CDC25 ± S. Cerevesiae guanine nucleotide dissociation stimulator for yeast Ras (Broek et al., 1987) ; ste6 ± S. pombe sterile 6, guanine nucleotide dissociation stimulator for yeast ras (Hughes et al., 1990) rsc oncogene homologous to Ral-GDS D D'Adamo et al truncated region of rgr present in rsc is, by itself, tumorigenic (Table 2 ). These results indicate that the tumorigenic potential of rsc is due either to the truncation or overexpression of rgr.
The origin of the genetic alteration that elicited the formation of rsc was then addressed. Using primers speci®c for both sides of the fusion, PCR ampli®cation was performed on DNAs from the original rabbit SSC (O1) and the subsequent rounds of nude mouse tumors derived from it. This experiment indicated that the speci®c, band of 600 bases was present from the primary nude mouse tumor onward, but not in the original O1 tumor, indicating that the gene rearrangement had taken place during the ®rst round of gene transfer ( Figure 6 ). This event permitted the fortuitous identi®cation and isolation of rgr, a new gene with oncogenic potential.
rsc transforming properties
The biological properties of the rsc oncogene were analysed to con®rm its oncogenic nature. The nude mouse tumorigenesis assay was used to detect and subsequently isolate the oncogene. NIH3T3 cells were transfected with the full length rsc cDNA subcloned into the mammalian expression vector pBK-CMV (Alting- Mees et al., 1992) . This construct was utilized to produce clones stably transfected with rsc. Some of these clones, as well as a pool of 3T3 cells transfected with the construct, were injected into nude mice. These experiments demonstrate that rsc is tumorigenic, with a latency period of approximately 3 weeks (Table 1) . To further characterize the transforming properties of rsc, the rsc expression construct was analysed in the focus forming assay and in the anchorage independence assay (Table 1) . rsc scored negative in both tests, con®rming that the nude mouse tumorigenesis assay detects transforming activities missed by less cumbersome, conventional assays.
To investigate if this oncogene induced growth properties in the host cells could be measured in vitro, growth in low serum was measured. 3T3 cells transfected with rsc have a signi®cant growth advantage in 1% serum, where they continue to proliferate, while the parental cells, or those transfected with vector alone, fail to proliferate in these conditions (Figure 7 ). In addition, rsc-transfected cells exhibit decreased contact inhibition and a refractile morphology in culture (data not shown).
Analysis of the related biochemical pathways in rsc transformed cells
The sequence homology of rsc to ral-GDS suggested that Rsc might be involved in the same pathways as Ral-GDS. The product of this gene has been shown to be an eector for Ras (Spaargaren and Bischo, 1994) , and activation of the Ras pathway was undertaken next. The ®rst experiments addressed the possibility that rsc transformed cells might have an increase in activated Ras, if there was any eect in the pathway upstream of Ras. This possibility was investigated by measuring the Ras GTP loading. Those experiments indicated that rsc transformed cells do not show increased Ras activation when compared to parental untransformed cells. Analysis of a downstream marker for activation of the main Ras pathway, MAP kinase, was then performed. Myelin basic protein phosphorylation assays showed that the conventional Ras pathway is not activated in rsc transformed cells. The most important biochemical characterization of the rsc gene product was to determine if it has exchange activity for Ral, due to its signi®cant homology to Ral-GDS. Experiments using a GST-Rgr bacterial fusion protein showed that GST-Rgr has exchange activity for Ral when compared to the GST protein itself and to spontaneous dissociation (Figure 8 ). In addition, this activity appears to be speci®c, since it did not elicit any 
Discussion
We have isolated and partially characterized a novel oncogene, using the nude mouse tumorigenicity assay. This assay permits the detection of genes with oncogenic properties that may not be identi®ed in a conventional focus formation assay. The isolation procedure took advantage of species-speci®c repetitive sequences. In this study we used the dierence between a mouse background and rabbit incoming sequences to follow the oncogene (Figure 1 ). We believe this is the ®rst rabbit gene isolated using this strategy. Exon detection in the isolated library clones was accomplished by using labeled cDNA from transformed cells to hybridize Southern blots of the phage DNAs (data not shown). This provided a rapid and ecient screening that facilitated the search. The use of RACE and RT ± PCR facilitated the isolation of the full length oncogene cDNA, and of its normal counterparts, especially given the low levels of expression of rgr in the tissues analysed (data not shown).
The mechanism of activation of this new oncogene, named rsc, is most likely a rearrangement that occurred during the initial gene transfer (Figure 6 ). This event brought together two genes, the rHR23A gene and a new member of the ral-GDS family (Albright et al., 1993; Kikuchi et al., 1994; Wolthuis et al., 1996) , rgr. Molecular analysis of the oncogene cDNA and its normal rabbit counterparts indicate that only the rgr portion of the oncogene is tumorigenic (Table 2 ). In contrast, the rHR23A portion of the oncogene and its full length normal counterpart are not 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Hind III Bam HI Figure 6 The fusion between the rabbit RAD23 homologue and the ral/GDS-related gene was not present in the original rabbit squamous cell carcinoma (O1) or in any of the other DMBA induced SCCs. Rather, the fusion occurred during the formation of the primary nude mouse tumor. (a) Polymerase Chain Reaction (PCR) ampli®cation of rsc was performed from 100 ng of genomic DNA from each sample. The primers span the junction between rHR23A and the ral/GDS-related region of rsc. The rHR23A speci®c primer was HHR505-525 (5'-CTAGT-GACGGGCTCTGAGTA-3'); the ral/GDS-related primer was 3Hpa5' (5'-TGGGACCAGGGATTCCTCCA-3'). The PCR conditions were 30 cycles at 948C for 30 s, 558C for 30 s and 728C for 2 min. The samples were as follows: (1) ± lambda DNA/EcoRI and HindIII; (2) ± 3T3; (3) ± rabbit liver; (4) ± 3N5 rabbit SCC; (5) ± G2#1 rabbit SCC; (6) ± G3#1 rabbit SCC; (7) ± O1 rabbit SCC; (8) ± O1 primary nude mouse tumor, from O1 SCC DNA transfected into 3T3 cells and injected into a nude mouse; (9) ± O2 rabbit SCC; (10) ± R3 rabbit SCC; (11) ± R24 rabbit SCC; (12) ± R26 rabbit SCC; (13) ± RSC 3.1; (14) ± no DNA. The arrow shows the 600 base pair product of the PCR ampli®cation, which is present only in lanes 8 and 13. (b) Twenty micrograms of genomic DNA from each sample (3T3, O1, SCC, O1 primary nude mouse tumor, NRL [Normal Rabbit Liver] and RSC 3.1) were digested with the listed restriction enzymes and analysed by Southern blotting (0.8% gel). The nitrocellulose ®lter was probed with a 691 base pair Sacl/NarI restriction fragment of rsc, which spans the junction region of the gene Figure 7 rsc transfected cells grow in low serum. The growth of cells in low serum was determined as described in Materials and methods. 3T3 cells transfected with the pBK-CMV vector alone or the pBK-CMV vector with the rsc cDNA in the forward orientation (RSC-C1) were seeded at equal density and grown in either 1% or 10% calf serum. Cells were counted 3, 6, 9 and 12 days after plating. Each time point was determined in triplicate Experiments in progress will precisely determine the contribution to activation from overexpression of the normal rgr product when placed under the control of another promoter, or to a dierent function conferred to the Rgr protein by the truncation. Surprisingly, in our hands, rsc in reverse orientation was also tumorigenic (Table 1) , albeit with a longer latency. Western analysis of these tumors did demonstrate rsc expression, probably from cryptic promoters (data not shown), explaining its tumorigenic behaviour.
One of the intriguing features of this oncogene is that in the normal tissues analysed ± brain, liver, skin, spleen, muscle, kidney and lung ± rgr transcripts were present at very low levels. In fact, it was necessary to use RT ± PCR to detect rgr expression. These results suggest that the normal rgr gene plays a very speci®c role in cell physiology, perhaps during embryonic development, and its inappropriate expression is what elicits the tumorigenic phenotype. The investigation of the temporal and spatial expression of rgr may provide clues about its physiological function. Another unusual attribute of this new oncogene is that it is able to alter cell morphology, but it is unable to cause focus formation or to confer anchorage independence in semisolid media. We hypothesize that, for RSC 3.1 cells, growth in soft agar (Table 1) is probably due to the accumulation of additional alterations after its continued growth in vitro. This dierence between RSC 3.1 and cells freshly transformed with rsc could be useful to dissect the underlying changes responsible for anchorage independence. By contrast, this oncogene is quite potent in the nude mouse tumorigenesis assay, producing tumors within 4 weeks of injection. This dissociation between dierent transforming properties should eventually be useful to investigate the function of the signal transduction pathways activated by this oncogene.
The homology of Rgr to Ral-GDS is highly suggestive of which signal transduction pathways the gene could be involved with. Although the overall identity between the two proteins is only 40%, it rises to 72% over a 100 amino acid stretch in the catalytic domain (Figure 4) , suggesting a strong functional relationship. This relationship was demonstrated by the nucleotide exchange activity for Ral shown by recombinant GST-Rgr protein (Figure 8 ), which appears to be Ral speci®c, since it did not show exchange activity for Ras or Ran. Although the bacterial GST-Rgr fusion protein exhibited only modest exchange activity, this could be a result of the lack of post-translational modi®cations that would enhance its catalytic activity. Other laboratories have also reported diculty in detecting exchange activity from bacterially expressed Ral-GDS proteins. Expression in eukaryotic vectors might boost its activity.
The placement of this new oncogene in the ral-GDS family opens interesting avenues to analysing important pathways of cell proliferation. Ral-GDS has been shown to be an eector of Ras (Spaargaren and Bischo, 1994) , although it does not seem to be transforming by itself (L Feig, personal communication). Nevertheless, recent reports indicate that Ral can enhance foci formation induced by Ras and Raf (Urano et al., 1996) and Ral-GDS itself can produce a similar eect with raf (White et al., 1996) . The Rsc oncogene protein identi®ed here lacks the Ras interacting domain that is present in Ral-GDS, and it would seem to be stimulating the Ral pathway independently of Ras. We have evidence that normal rabbit cells contain messages lacking the Ras interacting domain. We have not ruled out that these are splicing variants. The existence of an exchange factor for Ral which lacks the Ras interacting domain suggests that Ral might also be activated through a Ras independent pathway. One intriguing observation is that Ral may stimulate phospholipase D (Jiang et al., 1995) , providing a new link between this branch of the Ras pathway and lipid metabolism. Subsequent experiments will show if Rsc is also able to stimulate PLD.
The experiments described in the present study have identi®ed a novel oncogene, termed rsc, which resulted from a fusion between rHR23A and rgr, a member of the ral-GDS gene family. The primary sequence of the cDNA and the biochemical function of the oncogene product indicate that Ral-stimulated pathways are also involved in tumorigenesis. These results open the way for further characterization of the biological properties of that pathway.
Materials and methods
Cells and media
Cells utilized included NIH3T3 (mouse ®broblasts), RK13 (epithelial from rabbit kidney) (Beale et al., 1963) , RSC 3.1 (mouse ®brosarcoma, established in the lab from an rscinduced nude mouse tumor) and 3T3 transformants with the dierent rHR23A or rgr constructs. These cells were maintained in DMEM in 10% calf serum, unless otherwise indicated. They were split every 3 days. Special care was taken for the stocks of NIH3T3 to split them when they were still sparse to prevent the appearance of variants with abnormal growth properties. RSC 3.1 cells were established by explanting a ®nely minced nude mouse tumor that had been treated with trypsin and collagenase to facilitate tumor cell dissociation. The cells were initially cultured in DMEM with 10% fetal bovine serum, 50 units/ml of penicillin and 50 mg/ml streptomycin.
Transformation and tumorigenesis assays
NIH3T3 cells were transfected with 1 mg of vector DNA and 10 mg of 3T3 carrier DNA per plate for colony selection or focus formation as previously described (Guerrero et al., 1984) . Anchorage independence assays were performed following previously published protocols (Bouck and di Mayorca, 1979) . Cells were seeded at 10 4 per 10 cm plate on a 0.3% agarose layer on top of a 0.8% base in DMEM and 10% calf serum. Colony formation (more than 25 cells) was monitored at the microscope after 2 weeks. Nude mouse tumorigenesis assays were performed as previously described (Newcomb et al., 1988) . The mice were monitored for at least 8 weeks for tumor development. Proliferation capacity at low serum was measured by seeding 10 cm plates with 5610 4 cells in the presence of DMEM in 1% or 10% calf serum. At increasing times, plates from each cell group were trypsinized and the number of cells present at each time point was counted.
Nucleic acid extraction and analysis
DNAs and RNAs were extracted as previously described (Guerrero et al., 1984) . DNAs were digested with rsc oncogene homologous to Ral-GDS D D'Adamo et al restriction enzymes following the manufacturer's recommendations, subjected to agarose gel electrophoresis, and transferred for Southern blot as previously described (Guerrero et al., 1984) . RNAs were, when indicated, subjected to further puri®cation to isolate poly (A) + transcripts. RNAs were subjected to agarose gel electrophoresis and transfer for Northern blot as previously described (Guerrero et al., 1984) . DNA probes were 32 Plabeled using the random primer method (Ausubel et al., 1987) . To identify transcribed sequences present in genomic fragments, phage inserts were digested with several restriction enzymes and subjected to agarose gel electrophoresis and blotting. The ®lters were hybridized with 32 P labeled cDNA synthesized from poly (A) + RNA from RSC 3.1 cells.
Library construction
Genomic libraries were constructed from a secondary nude mouse tumor DNA and from the nude mouse tumorderived RSC 3.1 cell line. DNAs were partially digested by Sau3a and size fractionated by preparative agarose gel electrophoresis. DNA between 12 and 20 kb was electroeluted from the gel and puri®ed over an Elutip-D column (Schleicher & Schuell) . The size-selected DNA was ligated to phage arms (Lambda FIX II, Stratagene) at a molar ratio of 1:2 (arms:insert) and subsequently packaged according to the manufacturer's instructions (Gigapack, Stratagene). An excess of 10 6 plaques was screened for each library using 32 P nick translated probes. The rabbit repetitive sequence was used to probe the secondary nude mouse tumor library, or a single copy rabbit probe to probe the RSC 3.1 library. Positive plaques underwent three rounds of screening and puri®cation, until single plaques were isolated. DNA was prepared from these phage clones by polyethylene glycol precipitation and anion exchange chromatography (Qiagen) according to the manufacturer's instructions. The inserts were separated from the vector by digestion with restriction endonuclease NotI and agarose gel electrophoresis.
DNA sequencing
The sequences of the isolated fragments were determined using the chain termination method (Sanger et al., 1977) . Reactions were performed according to the manufacturer's instructions using the Sequenase enzyme (United States Biochemical Corporation). Samples were analysed on a 6% polyacrylamide/8M urea gel. Some of the samples were analysed by automatic sequencing (Applied Biosystems). The sequence of rsc cDNA was determined in full from both strands. To facilitate the process, the cDNA was digested with restriction enzymes HpaII, Sau3a and PstI. Fragments of up to 500 base pairs were subcloned into pBluescript or pBK-CMV (Stratagene) and sequenced from the T3 and T7 promoter sites. Computer analysis of the data provided the relative position and orientation of the overlapping restriction fragments. When necessary, oligonucleotides were synthesized and used as primers to bridge the gaps.
PCR based protocols
The Rapid Ampli®cation of cDNA Ends (RACE) technique (Clontech) was used to clone overlapping partial cDNAs using exonic sequences detected in an isolated genomic fragment. One microgram of poly (A) + RNA was reverse transcribed into single stranded cDNA. Double stranded cDNA was synthesized with DNA polI, RNase H and DNA ligase. The double stranded cDNA was blunted with T4 DNA polymerase and ligated to an adapter primer. RACE reactions were carried out to obtain 5' and 3' fragments using one speci®c primer and one adapter primer for each fragment. RACE products were visualized by agarose gel electrophoresis or subsequent Southern analysis probed with the genomic fragment previously cloned. The appropriate products were subcloned into the vector pCR II using the TA Cloning Kit (Invitrogen). Reverse transcription PCR was performed with 1 mg of total or poly (A) + RNA to determine tissue expression. The starting material was oligo dT primed and reverse transcribed using MMLV reverse transcriptase (Gibco/ BRL) according to the manufacturer's instructions. For detection of rHR23A, PCR ampli®cation was performed for 30 cycles of 30 s at 948C denaturation and 2 min at 688C annealing/extension with primers 5' RACE and 3' RACE (Clontech). For detection of rgr, PCR ampli®cation was performed with primers 3Hpa3' (5'-TCAGCC-TACCTGGAGGAGACCTGGG-3') and 1Hpa5' (5'-AGG-CAGCTCCTCTGCAGTCCCAGCC-3') for 30 cycles of 30 s at 948C, 30 s at 558C and 2 min at 688C. Products that were not visible by ethidium staining on a 2% agarose gel were transferred to a nylon ®lter and probed with the 32 Plabeled rsc cDNA.
Ras guanine nucleotide binding assay
The relative amounts of GDP and GTP bound to p21 Ras were determined as previously described (DeClue et al., 1991) . Brie¯y, cells were plated at 10 6 per 10 cm plate and serum starved overnight. The cells were labeled for 6 h in phosphate free DMEM containing 0.25 mCi/ml of H 3 32 PO 4 (New England Nuclear). After incubation, the cells were lysed in the presence of 1% Triton X-100, 0.5% deoxycholate and 1% SDS. The lysates were immunoprecipitated with 5 mg of the pan-Ras monoclonal antibody Y13-259 and Protein G-Agarose (Oncogene Science). The guanine nucleotides were eluted by incubating the immunoprecipitates with 30 ml of elution buer (20 mM Tris pH 7.5, 20 mM EDTA and 2% SDS) at 758C for 10 min and vortexing. The eluates were extracted once with an equal volume of phenol:chloroform (1:1). The guanine nucleotides were resolved by thin layer chromatography on polyethylene-imine cellulose. Phosphorimager analysis (Molecular Dynamics) was used to visualize the samples and quantitate the amounts of GTP and GDP.
MAP kinase assay
Cells for the assays were trypsinized and plated at 10 6 per 10 cm plate. One day later they were serum starved for 12 h, then washed once with PBS and lysed in 0.6 ml of lysis buer (50 mM Tris pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , 1% NP-40, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM PMSF, 100 mM NaF, 1 mM Na 3 VaO 4 ) for 10 min on ice. The lysates were cleared by centrifugation at 12 000 g for 10 min at 48C and the protein concentration was determined (Bradford, 1976) . The lysates (200 ± 400 mg) were incubated with 1 mg of polyclonal anti-MAPK antibody (ERK 16, Santa Cruz Biotechnology) and 20 ml of Protein G-Agarose for 2 ± 3 h rotating at 48C. The beads were washed four times with lysis buer minus protease and phosphatase inhibitors and twice with kinase buer (50 mM Tris pH 7.5, 10 mM MgCl 2 ). The kinase reaction was conducted by adding 25 ml of kinase buer containing 5 mCi of [g 32 P]ATP (New England Nuclear) and 25 mg of Myelin Basic Protein (Sigma) to the beads, and incubating at 308C for 30 min (Miyamoto et al., 1995) . The reaction was stopped by boiling the samples in loading buer for 2 min. The samples were separated by SDS ± PAGE on a 15% gel under reducing conditions (Sambrook et al., 1989) . The gel was subsequently ®xed and dried. A phosphorimager was used to visualize the samples and quantitate the amount of myelin basic protein phosphorylation. 
Guanine nucleotide Ral exchange assay
Measurement of the capacity of proteins to induce guanine nucleotide exchange from Ral was performed according to a previously described protocol (Albright et al., 1993) . The Rgr-pGEX fusion protein was puri®ed from bacteria. A Grb2-pGEX (a gift from J Schlessinger) fusion protein was puri®ed in the same way and used as a negative control. The exchange reaction was quantitated by previously loading 2 mg of Ral (a gift from L Feig), Ras (a gift from M Barbacid) or Ran (a gift from M Rush) in 200 ml of exchange buer (50 mM Tris pH 7.5, 10 mM EDTA, 5 mM MgCl 2 and 1 mg/ml BSA) including 10 mCi/ml of [a-32 P]GTP (3000 Ci/mmol) for 20 min at 378C. The loading was arrested with 200 ml of stop exchange buer (50 mM Tris pH 7.5, 15 mM MgCl 2 , 1 mg/ml BSA, 0.1 mM DTT and 0.1 mM GDP). The dissociation reaction was initiated by combining 10 ml of the fusion protein with 80 ml of the reaction mixture containing [a-
32 P]GTP-loaded Ral, Ras or Ran at 378C. The reaction was quenched at 10, 20 and 30 min intervals with 0.5 ml of stop buer and ®ltered through nitrocellulose ®lters. The ®lters were washed with 10 ml of stop buer and the measurement of the radioactivity in the ®lters was measured in a scintillation counter.
Preparation of Rgr fusion protein
A GST-Rgr fusion protein was generated using the vector pGEX-2T (Smith and Johnson, 1988 ). An rgr cDNA was made by RT ± PCR using the primers rgr5' end (5'-CAGCTTCCATCTCTGCACTGCTGCT-3') and rsc3' (5'-GTTAACTTTAATAAAACTCTACTAGGGAG-3'), and subcloned into pCR II. The rgr insert was then removed from pCR II using EcoRI, and ligated into the vector pGEX-2T at the EcoRI site. The presence and orientation of inserts were veri®ed by DNA miniprep analysis. The ability of clones to produce a fusion protein was assayed by growing them in the presence of the inducer IPTG. The bacteria were pelleted by centrifugation, resuspended in PBS, and lysed by sonication. The lysates were incubated with glutathione-agarose (Sigma), washed three times with 1% Triton X-100, and boiled in sample loading buer (Laemmli, 1970) . The samples were separated on a 15% polyacrylamide gel (Sambrook et al., 1989) and visualized by Coomassie blue staining. One colony that produced a fusion protein was selected for large scale production of GST-Rgr. One litre of LB containing 50 mg/ml ampicillin was inoculated with 1 ml of saturated culture and grown for 3 h. IPTG (0.1 M) was added to a ®nal concentration of 0.1 mM and the culture was incubated for seven more hours at 308C in a 200 r.p.m. shaker. The fusion protein for exchange assays was puri®ed as described above, except that after the washes, the protein was eluted in 25 mM reduced glutathione (Boehringer Mannheim), and titrated with 1 M Tris until the pH was 5.0.
